OrbiMed Genesis Fund, L.P. · CIK 1796304
OrbiMed Genesis Fund, L.P.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
0
Amendments
1
Activity
Dec 5, 2025
through Dec 5, 2025
through Dec 5, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- —
- Reported exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(7)
- Reported amount sold
- $353,340,923
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Likely investment adviser (not guaranteed)
Best-effort name match against Form ADV. Click through for AUM, employees, and disciplinary disclosures.
-
ORBIMED CAPITAL LLC
medium CRD 801-61952
Similar issuer names (identity not confirmed)
- OrbiMed Genesis Fund, Ltd. CIK 1808344 · Cayman Islands
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- OrbiMed Asia Partners VI, L.P. · CIK 2087034
- OrbiMed Genesis Fund, Ltd. · CIK 1808344
- OrbiMed Partners II, L.P. · CIK 1324240
- OrbiMed Partners, Ltd. · CIK 1459984
- OrbiMed Private Investments X, LP · CIK 2087033
Form D filings (1)
-
0000902664-25-005202D/A · Dec 5, 2025 · Pooled Investment FundSold: $353,340,923